Mammary fibroadenomatous hyperplasia in a young cat attributed to treatment with megestrol acetate.
A male, neutered cat was presented for lethargy, reluctance to walk, and mammary enlargement after recent treatment with megestrol acetate. Mammary fibroadenomatous hyperplasia was diagnosed on the basis of history, clinical signs, and histopathological findings. Pathogenesis, clinical signs, and treatment options for mammary fibroadenomatous hyperplasia attributed to megestrol acetate treatment are discussed.
MacDougall
Lori D
LD
Western College of Veterinary Medicine, University of Saskatchewan, 52 Campus Drive, Saskatoon, Saskatchewan S7N 5B4.
D000818:Animals; D002371:Cat Diseases / Q000139:chemically induced* / Q000473:pathology; D002415:Cats; D018226:Fibroadenoma / Q000139:chemically induced / Q000473:pathology / Q000662:veterinary*; D005348:Fibrocystic Breast Disease / Q000139:chemically induced / Q000473:pathology / Q000662:veterinary*; D006965:Hyperplasia / Q000139:chemically induced / Q000473:pathology / Q000662:veterinary; D008297:Male; D008321:Mammary Glands, Animal / Q000473:pathology*; D019290:Megestrol Acetate / Q000008:administration & dosage / Q000009:adverse effects*
D019290:Megestrol Acetate